Report Summary
Eternity Insights has published a new study on Global Diabetes Injection Pens Market focusing on key segments as by Type (Reusable Pens, Disposable Pens, Other), by Application (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Diabetes Injection Pens Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Diabetes Injection Pens Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Diabetes Injection Pens Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Diabetes Injection Pens Market Segmentation:
Diabetes Injection Pens Market, By Type
- Reusable Pens
- Disposable Pens
- Other
Diabetes Injection Pens Market, By Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/ Centers
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Diabetes Injection Pens market in terms of demand generation. The Diabetes Injection Pens market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Diabetes Injection Pens market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Diabetes Injection Pens Market Taxonomy:
To learn more about this report
Global Diabetes Injection Pens Market Competitive Landscape
The global Diabetes Injection Pens market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Novo Nordisk A/S
- Eli Lilly and Company
- AstraZeneca plc
- Biocon Ltd.
- Sanofi S.A.
- Becton
- Dickinson and Company
- Owen Mumford Ltd.
- Jiangsu Delfu Co.
- Ltd.
- Wockhardt Ltd.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Reusable Pens, Disposable Pens, Other |
| By Application Outlook |
Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon Ltd., Sanofi S.A., Becton, Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co., Ltd., Wockhardt Ltd. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Diabetes Injection Pens Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Diabetes Injection Pens Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Diabetes Injection Pens Market Performance
2.3 USA Diabetes Injection Pens Market Performance
2.4 Europe Diabetes Injection Pens Market Performance
2.5 Japan Diabetes Injection Pens Market Performance
2.6 Korea Diabetes Injection Pens Market Performance
2.7 India Diabetes Injection Pens Market Performance
2.8 Southeast Asia Diabetes Injection Pens Market Performance
2.9 South America Diabetes Injection Pens Market Performance
3 Global Diabetes Injection Pens Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Diabetes Injection Pens Market Performance (Volume)
3.3 USA Diabetes Injection Pens Market Performance (Volume)
3.4 Europe Diabetes Injection Pens Market Performance (Volume)
3.5 Japan Diabetes Injection Pens Market Performance (Volume)
3.6 Korea Diabetes Injection Pens Market Performance (Volume)
3.7 India Diabetes Injection Pens Market Performance (Volume)
3.8 Southeast Asia Diabetes Injection Pens Market Performance (Volume)
3.9 South America Diabetes Injection Pens Market Performance (Volume)
4 Competitive Analysis
4.1 Novo Nordisk A/S
4.1.1 Novo Nordisk A/S Profiles
4.1.2 Novo Nordisk A/S Product Information
4.1.3 Novo Nordisk A/S Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.1.4 Novo Nordisk A/S Diabetes Injection Pens Business Performance
4.1.5 SWOT Analysis
4.2 Eli Lilly and Company
4.2.1 Eli Lilly and Company Profiles
4.2.2 Eli Lilly and Company Product Information
4.2.3 Eli Lilly and Company Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.2.4 Eli Lilly and Company Diabetes Injection Pens Business Performance
4.2.5 SWOT Analysis
4.3 AstraZeneca plc
4.3.1 AstraZeneca plc Profiles
4.3.2 AstraZeneca plc Product Information
4.3.3 AstraZeneca plc Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.3.4 AstraZeneca plc Diabetes Injection Pens Business Performance
4.3.5 SWOT Analysis
4.4 Biocon Ltd.
4.4.1 Biocon Ltd. Profiles
4.4.2 Biocon Ltd. Product Information
4.4.3 Biocon Ltd. Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.4.4 Biocon Ltd. Diabetes Injection Pens Business Performance
4.4.5 SWOT Analysis
4.5 Sanofi S.A.
4.5.1 Sanofi S.A. Profiles
4.5.2 Sanofi S.A. Product Information
4.5.3 Sanofi S.A. Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.5.4 Sanofi S.A. Diabetes Injection Pens Business Performance
4.5.5 SWOT Analysis
4.6 Becton, Dickinson and Company
4.6.1 Becton, Dickinson and Company Profiles
4.6.2 Becton, Dickinson and Company Product Information
4.6.3 Becton, Dickinson and Company Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.6.4 Becton, Dickinson and Company Diabetes Injection Pens Business Performance
4.6.5 SWOT Analysis
4.7 Owen Mumford Ltd.
4.7.1 Owen Mumford Ltd. Profiles
4.7.2 Owen Mumford Ltd. Product Information
4.7.3 Owen Mumford Ltd. Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.7.4 Owen Mumford Ltd. Diabetes Injection Pens Business Performance
4.7.5 SWOT Analysis
4.8 Jiangsu Delfu Co., Ltd.
4.8.1 Jiangsu Delfu Co., Ltd. Profiles
4.8.2 Jiangsu Delfu Co., Ltd. Product Information
4.8.3 Jiangsu Delfu Co., Ltd. Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.8.4 Jiangsu Delfu Co., Ltd. Diabetes Injection Pens Business Performance
4.8.5 SWOT Analysis
4.9 Wockhardt Ltd.
4.9.1 Wockhardt Ltd. Profiles
4.9.2 Wockhardt Ltd. Product Information
4.9.3 Wockhardt Ltd. Diabetes Injection Pens Production, Revenue, Price and Gross Margin
4.9.4 Wockhardt Ltd. Diabetes Injection Pens Business Performance
4.9.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Diabetes Injection Pens Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Diabetes Injection Pens Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Diabetes Injection Pens Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Diabetes Injection Pens Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Diabetes Injection Pens Market Assessment by Regions
6.1 Global Diabetes Injection Pens Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Diabetes Injection Pens Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Diabetes Injection Pens Price (USD/Unit) by Regions (2014-2020)
6.4 Global Diabetes Injection Pens Gross Margin by Regions (2014-2020)
7 Diabetes Injection Pens Regional Analysis
7.1 China Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.2 USA Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.6 India Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
7.8 South America Diabetes Injection Pens Production, Revenue and Growth Rate (2014-2020)
8 Global Diabetes Injection Pens Consumption Assessment
8.1 Global Diabetes Injection Pens Consumption and Market Share by Regions (2014-2020)
8.2 Global Diabetes Injection Pens Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Diabetes Injection Pens Average Price (USD/Unit) by Regions (2014-2020)
9 Global Diabetes Injection Pens Sales Assessment by Regions
9.1 Global Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.2 China Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.3 USA Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.4 Europe Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.5 Japan Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.6 Korea Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.7 India Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.8 Southeast Asia Diabetes Injection Pens Sales and Sales Value (2014-2020)
9.9 South America Diabetes Injection Pens Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Diabetes Injection Pens Production and Revenue by Regions 2020-2026
12.1.2 China Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.7 India Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Diabetes Injection Pens Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Diabetes Injection Pens Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.3 China Diabetes Injection Pens Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.8 India Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.2.10 South America Diabetes Injection Pens Sales and Sales Value Forecast 2020-2026
12.3 Global Diabetes Injection Pens Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Reusable Pens
12.3.3 Disposable Pens
12.4 Global Diabetes Injection Pens Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Hospital Pharmacy
12.4.3 Retail Pharmacy
12.4.4 Online Sales
12.4.5 Diabetes Clinics/ Centers
12.5 Global Diabetes Injection Pens Price and Gross Margin Forecast
13.5.1 Global Diabetes Injection Pens Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Diabetes Injection Pens Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
